- Home
- FATE vs FC Comparison
FATE vs FC Comparison
Compare FATE & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FATE | FC |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.6M | 157.5M |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | FATE | FC |
|---|---|---|
| Price | $1.13 | $11.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $4.10 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 1.5M | 136.4K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.88 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $6,646,000.00 | ★ $267,067,000.00 |
| Revenue This Year | N/A | $3.02 |
| Revenue Next Year | $1.05 | $3.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $11.28 |
| 52 Week High | $1.94 | $30.88 |
Technical Indicators
Market Signals| Indicator | FATE | FC |
|---|---|---|
| Relative Strength Index (RSI) | 39.70 | 13.53 |
| Support Level | $0.96 | N/A |
| Resistance Level | $1.16 | $20.19 |
| Average True Range (ATR) | 0.13 | 0.67 |
| MACD | -0.04 | -0.07 |
| Stochastic Oscillator | 4.27 | 7.62 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About FC Franklin Covey Company
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.